ARAY
Accuray Incorporated
NASDAQ · Healthcare · Medical - Devices · US
$0.27
+0.30%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.2x
Market Cap
$31.87M
MomentumView details →
1D Return
+0.30%
YTD Return
−68.28%
RSI (14)
45.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.2x
Market Cap
$31.87M
RSI (14)
45.6
MomentumView details →
1D Return
+0.30%
YTD Return
−68.28%
SummaryUpdated Jun 1, 2026
Accuray Incorporated (NASDAQ:ARAY) is a medical device company founded in 1990 and headquartered in Madison, Wisconsin. The company went public in February 2007 and specializes in designing, developing, manufacturing, and selling advanced radiosurgery and radiation therapy systems for cancer treatment. Accuray serves hospitals and treatment facilities globally, with operations spanning the United States, Canada, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific region. The company has established itself as a key player in the precision radiation therapy market, with over 1,000 systems installed worldwide.
Similar companies
Latest newsMore news →
Accuray Inc reported Q4 2026 revenue of $100.9 million, down 21% year-over-year, with a net loss of $1.9 million and diluted EPS of -$0.02.17d agoAccuray Inc. signed a private placement of Series A Convertible Preferred Stock and warrants, raising $15 million in cash and converting $40 million of existing debt into equity.38d ago